PKCδ can be phosphorylated by CDCP1/SFK complex through the interaction of the C2 domain of PKCδ to enhance anoikis resistance and migration/invasion abilities of cancer cells [13, 14, 29]. The gene discussed is CDCP1; the disease is cancer.